-
PublishedApril 11, 2021
Some GOP-led states target abortions done through medication
Supporters of medical abortions say that option is important for economically disadvantaged people and those in rural areas who don't have easy access to a clinic.
-
PublishedApril 6, 2021
Nearly half of new U.S. virus infections are in just 5 states
The concentration of infections is putting pressure on the federal government to consider changing how it distributes vaccines by sending more doses to hot spots.
-
PublishedApril 5, 2021
FDA OKs first new ADHD drug in over a decade for children
Quelbree is a daily capsule for kids 6 to 17.
-
PublishedApril 5, 2021
Some businesses want masks on, even as states drop mandates
The law sides with owners as a company's premises are private property.
-
PublishedApril 5, 2021
With new law, Maine delegation pushes for speedy help for veterans with dementia
The delegations of Maine and Alaska want the U.S. Department of Veterans Affairs to work quickly to implement a law that gives the VA the ability to waive eligibility requirements for homecare.
-
PublishedApril 4, 2021
Vaccine passports offer public health benefits but also stir debate
Requiring proof of vaccination for certain types of travel or admittance to large-scale gatherings is under consideration, but privacy and equity concerns may prevent widespread implementation.
-
PublishedApril 3, 2021
U.K.: Benefits outweigh risks for AstraZeneca despite 7 deaths
They died from rare blood clots after getting the jab.
-
PublishedMarch 30, 2021
BioNTech raises COVID vaccine target to 2.5 billion doses
The company also announced it's developing two new formulations: a ready-to-use vaccine that can be stored at fridge temperatures and a freeze-dried version that could be stockpiled.
-
PublishedMarch 29, 2021
COVID-19 vaccines 90% effective in real-world U.S. study
More than 93 million Americans have received at least one dose and over 51 million are fully inoculated.
-
PublishedMarch 22, 2021
AstraZeneca: U.S. data shows vaccine effective for all ages
The trials included 30,000 volunteers and had a 79 percent efficacy rate.
- ← Previous Page
- 1
- …
- 43
- 44
- 45
- 46
- 47
- …
- 106
- Next Page →